Enable Injections Announces $215 Million in Series C Financing
The funding from Magnetar will help enFuse continue to redefine intravenous drug delivery by meaningfully scaling development and commercialization efforts.
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
The funding from Magnetar will help enFuse continue to redefine intravenous drug delivery by meaningfully scaling development and commercialization efforts.
NaoX was co-founded in 2018 by Hugo Dinh, a graduate from Ecole Polytechnique, and Michel Le Van Quyen, a research director at Inserm, respectively CEO and Chief Scientific Officer.
The funds raised will support the next stage of development and initiation of a First in Human pilot study.